PharmacogeneticsIndividualized MedicineCytochrome P-450 CYP2D6Polymorphism, GeneticVitamin K Epoxide ReductasesAryl Hydrocarbon HydroxylasesBiomarkers, PharmacologicalGenotypeDrug-Related Side Effects and Adverse ReactionsPharmaceutical PreparationsWarfarinMetabolic Detoxication, DrugDrug TherapyPharmacy ResidenciesGenetic VariationPolymorphism, Single NucleotideGenetic TestingDihydrouracil Dehydrogenase (NADP)MethyltransferasesCytochrome P-450 Enzyme SystemCytochrome P-450 CYP3ADrug DesignMixed Function OxygenasesPharmacokineticsAnticoagulantsDrug Dosage Calculations6-MercaptopurineSleep Arousal DisordersAzathioprineStevens-Johnson SyndromeOrganic Anion TransportersCodeineGlucuronosyltransferasePhenotypeAntipsychotic AgentsDrug HypersensitivityClinical Trials as TopicGene FrequencyArylamine N-AcetyltransferaseBiotransformationDideoxynucleosidesAllelesReceptors, Adrenergic, beta-1Drug InteractionsAcenocoumarolGenome, HumanCatechol O-MethyltransferaseForecastingOxidoreductases, N-DemethylatingTreatment OutcomeP-GlycoproteinDose-Response Relationship, DrugHaplotypes